Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 1c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• Nvidia underperforms peers as report sparks rack delay worries
• Supreme Court declines to block Texas law requiring age verification and parental consent to download apps
• FIFA denies Belgium appeal over Balogun eligibility